Author Correction: Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.

Schumacher FR., Olama AAA., Berndt SI., Benlloch S., Ahmed M., Saunders EJ., Dadaev T., Leongamornlert D., Anokian E., Cieza-Borrella C., Goh C., Brook MN., Sheng X., Fachal L., Dennis J., Tyrer J., Muir K., Lophatananon A., Stevens VL., Gapstur SM., Carter BD., Tangen CM., Goodman PJ., Thompson IM., Batra J., Chambers S., Moya L., Clements J., Horvath L., Tilley W., Risbridger GP., Gronberg H., Aly M., Nordström T., Pharoah P., Pashayan N., Schleutker J., Tammela TLJ., Sipeky C., Auvinen A., Albanes D., Weinstein S., Wolk A., Håkansson N., West CML., Dunning AM., Burnet N., Mucci LA., Giovannucci E., Andriole GL., Cussenot O., Cancel-Tassin G., Koutros S., Beane Freeman LE., Sorensen KD., Orntoft TF., Borre M., Maehle L., Grindedal EM., Neal DE., Donovan JL., Hamdy FC., Martin RM., Travis RC., Key TJ., Hamilton RJ., Fleshner NE., Finelli A., Ingles SA., Stern MC., Rosenstein BS., Kerns SL., Ostrer H., Lu Y-J., Zhang H-W., Feng N., Mao X., Guo X., Wang G., Sun Z., Giles GG., Southey MC., MacInnis RJ., FitzGerald LM., Kibel AS., Drake BF., Vega A., Gómez-Caamaño A., Szulkin R., Eklund M., Kogevinas M., Llorca J., Castaño-Vinyals G., Penney KL., Stampfer M., Park JY., Sellers TA., Lin H-Y., Stanford JL., Cybulski C., Wokolorczyk D., Lubinski J., Ostrander EA., Geybels MS., Nordestgaard BG., Nielsen SF., Weischer M., Bisbjerg R., Røder MA., Iversen P., Brenner H., Cuk K., Holleczek B., Maier C., Luedeke M., Schnoeller T., Kim J., Logothetis CJ., John EM., Teixeira MR., Paulo P., Cardoso M., Neuhausen SL., Steele L., Ding YC., De Ruyck K., De Meerleer G., Ost P., Razack A., Lim J., Teo S-H., Lin DW., Newcomb LF., Lessel D., Gamulin M., Kulis T., Kaneva R., Usmani N., Singhal S., Slavov C., Mitev V., Parliament M., Claessens F., Joniau S., Van den Broeck T., Larkin S., Townsend PA., Aukim-Hastie C., Gago-Dominguez M., Castelao JE., Martinez ME., Roobol MJ., Jenster G., van Schaik RHN., Menegaux F., Truong T., Koudou YA., Xu J., Khaw K-T., Cannon-Albright L., Pandha H., Michael A., Thibodeau SN., McDonnell SK., Schaid DJ., Lindstrom S., Turman C., Ma J., Hunter DJ., Riboli E., Siddiq A., Canzian F., Kolonel LN., Le Marchand L., Hoover RN., Machiela MJ., Cui Z., Kraft P., Amos CI., Conti DV., Easton DF., Wiklund F., Chanock SJ., Henderson BE., Kote-Jarai Z., Haiman CA., Eeles RA., Profile Study None., Australian Prostate Cancer BioResource (APCB) None., IMPACT Study None., Canary PASS Investigators None., Breast and Prostate Cancer Cohort Consortium (BPC3) None., PRACTICAL (Prostate Cancer Association Group to Investigate Cancer-Associated Alterations in the Genome) Consortium None., Cancer of the Prostate in Sweden (CAPS) None., Prostate Cancer Genome-wide Association Study of Uncommon Susceptibility Loci (PEGASUS) None., Genetic Associations and Mechanisms in Oncology (GAME-ON)/Elucidating Loci Involved in Prostate Cancer Susceptibility (ELLIPSE) Consortium None.